Sterling Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Sell	11,270 -6,864	-38%	-$153K	﹤0.01%	1070
2025 Q4	$469K	Buy	18,134 +393	+2%	+$9.35K	0.01%	959
2025 Q3	$457K	Buy	17,741 +1,776	+11%	+$43.6K	0.01%	982
2025 Q2	$382K	Buy	15,965 +410	+3%	+$10.3K	0.01%	1048
2025 Q1	$387K	Buy	15,555 +14,192	+1,041%	+$340K	0.01%	967
2024 Q4	$25.7K	Buy	1,363 +1,208	+779%	+$21.2K	﹤0.01%	1801
2024 Q3	$2.33K	Buy	+155	New	+$2.65K	﹤0.01%	2119
2015 Q4	–	Sell	-7,545	Closed	-$310K	–	1021
2015 Q3	$310K	Buy	+7,545	New	+$462K	﹤0.01%	860
2015 Q1	–	Sell	-2,949	Closed	-$261K	–	941
2014 Q4	$261K	Buy	2,949 +79	+3%	+$7.47K	﹤0.01%	858
2014 Q3	$278K	Buy	+2,870	New	+$279K	﹤0.01%	827